GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NovMetaPharma Co Ltd (XKRX:229500) » Definitions » General and Admin. Expense

NovMetaPharma Co (XKRX:229500) General and Admin. Expense : ₩186.71 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is NovMetaPharma Co General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. NovMetaPharma Co's General and Admin. Expense for the six months ended in Dec. 2023 was ₩186.71 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩186.71 Mil.

NovMetaPharma Co General and Admin. Expense Historical Data

The historical data trend for NovMetaPharma Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovMetaPharma Co General and Admin. Expense Chart

NovMetaPharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only 203.26 172.51 172.66 158.82 186.71

NovMetaPharma Co Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only 203.26 172.51 172.66 158.82 186.71

NovMetaPharma Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩186.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovMetaPharma Co General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of NovMetaPharma Co's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

NovMetaPharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NovMetaPharma Co Ltd (XKRX:229500) » Definitions » General and Admin. Expense
Comparable Companies
XKRX:017180 XKRX:044960 XKRX:053950 XKRX:239610 XKRX:260660 XKRX:175250 XKRX:007370 XKRX:041910 XKRX:200230 XKRX:314140 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
727 13, Gangnam-gu, Seoul eonju layer, Seoul, KOR
Website
http://www.novmeta.com
NovMetaPharma Co Ltd researches and develops new medicines and health supplements for metabolic diseases. The company is developing a therapeutic agent that is in Phase 2a clinical trial for Type 2 diabetes and obesity. It also develops therapeutic agents for Alzheimer's disease, immune system diseases, osteoporosis, and non-alcoholic fatty liver diseases.

NovMetaPharma Co Headlines

No Headlines